Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04638673 · ClinicalTrials.gov registry record · Phase 2
NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
NCT04638673 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 13 participants.
The verdict
NCT04638673, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of the research is to test out a new form of treatment that examines stimulation of a nerve in the participant's ear. This is called transcutaneous (through the skin) auricular (ear) vagus nerve stimulation (taVNS) which means that the participant will receive stimulation through the ear. The taVNS device looks like an ear bud used with a smart phone or computer. The study team is investigating whether or not taVNS can treat neurologic symptoms of COVID-19 which are termed NEUROCOVID. Some symptoms the participant may experience are new onset anxiety, depression, vertigo, loss of smell, headaches, fatigue, irritability, etc. This study is entirely online and all assessments will be completed virtually.
Interventions
- DEVICE Soterix taVNS model 0125-LTE Stimulator - Active-Active Group
- DEVICE Soterix taVNS model 0125-LTE Stimulator - Sham-Active Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2020-11-19 |
| Est. Completion | 2021-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04638673
The ClinicalTrials.gov registry entry for NCT04638673 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Soterix taVNS model 0125-LTE Stimulator - Active-Active Group is the first listed.
NCT04638673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04638673 about?
NCT04638673 is a clinical study titled "NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis". The purpose of the research is to test out a new form of treatment that examines stimulation of a nerve in the participant's ear. This is called transcutaneous (through the skin) auricular (ear) vagus nerve stimulation (taVNS) which means that the participant will receive stimulation through the ear...
What is the current status of trial NCT04638673?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2020-11-19. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT04638673?
The interventions under investigation include: Soterix taVNS model 0125-LTE Stimulator - Active-Active Group (DEVICE), Soterix taVNS model 0125-LTE Stimulator - Sham-Active Group (DEVICE).
Who is sponsoring clinical trial NCT04638673?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.